Galderma Group AG (GALD) Price & Analysis

Compare

1 Followers

GALD Stock Chart & Stats

Day’s Range― - ―

52-Week RangeCHF64.75 - CHF119.60

Previous CloseN/A

Volume230.69K

Average Volume (3M)1.10M

Market Cap

CHF27.53B

Enterprise ValueN/A

Total Cash (Recent Filing)CHF345.86M

Total Debt (Recent Filing)CHF2.65B

Price to Earnings (P/E)135.3

Beta0.94

Next Earnings

Jul 24, 2025

EPS Estimate

0.98

Last Dividend Ex-Date

Apr 25, 2025

Dividend Yield0.13%

Share Statistics

EPS (TTM)0.78

Shares Outstanding237,897,630

10 Day Avg. Volume2,710,588

30 Day Avg. Volume1,104,135

Financial Highlights & Ratios

PEG Ratio-28.58

Price to Book (P/B)3.03

Price to Sales (P/S)0.00

P/FCF Ratio82.63

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

CHF114.88

Price Target Upside19.02% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering5

Galderma Group AG News

PremiumRatings

Strong Future Prospects for Galderma Group AG: Buy Rating Supported by Product Uptake and Market Expansion Opportunities

6d ago

PremiumRatings

Galderma Group AG’s Nemluvio Drives Strong Buy Rating Amid Impressive Prescription Growth

12d ago

PremiumRatings

Galderma Group AG: Promising Growth Prospects and Strategic Positioning Justify Buy Rating

23d ago

PremiumRatings

Cautious Outlook for Galderma Group AG Amid Strong Sales and Tariff Concerns

2M ago

PremiumRatings

Positive Indicators and Strong Performance Drive Buy Rating for Galderma Group AG

2M ago

PremiumRatings

Buy Recommendation for Galderma Group AG Amid Growth Opportunities and Resilience to Tariff Impacts

2M ago

See All CH:GALD News

See All News >

Bulls Say, Bears Say

Bulls Say

Market ShareGalderma gained market shares in a slow growing US market.

Product LaunchNemluvio's launch is ahead of expectations, with a high initial share of biologic-naive patients across both indications.

Sales PerformanceQ1'25 sales beat driven by Nemluvio and positive neuromodulator phasing.

Bears Say

Earnings ImpactPharmaceutical tariffs on Therapeutic Derm and Dysport are likely to further affect earnings per share.

Growth ConcernsThe market is anticipating a growth slowdown in consumer-sensitive categories due to potential tariff impacts.

Tariff ImpactReciprocal tariffs on US Fillers and Biostimulators could directly impact earnings per share.

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

7.95%

Mutual Funds

― Other Institutional Investors

87.13% Public Companies and

Individual Investors

Detailed Ownership Overview >

GALD FAQ

What was Galderma Group AG’s price range in the past 12 months?

Galderma Group AG lowest stock price was CHF64.75 and its highest was CHF119.60 in the past 12 months.

What is Galderma Group AG’s market cap?

Galderma Group AG’s market cap is CHF27.53B.

When is Galderma Group AG’s upcoming earnings report date?

Galderma Group AG’s upcoming earnings report date is Jul 24, 2025 which is in 43 days.

How were Galderma Group AG’s earnings last quarter?

Galderma Group AG released its earnings results on Mar 06, 2025. The company reported CHF0.781 earnings per share for the quarter, the consensus estimate of CHF0.781 by CHF0.

Is Galderma Group AG overvalued?

According to Wall Street analysts Galderma Group AG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Galderma Group AG pay dividends?

Galderma Group AG pays a Notavailable dividend of CHF0.149 which represents an annual dividend yield of 0.13%. See more information on Galderma Group AG dividends here

What is Galderma Group AG’s EPS estimate?

Galderma Group AG’s EPS estimate is 0.98.

How many shares outstanding does Galderma Group AG have?

Galderma Group AG has 237,897,630 shares outstanding.

What happened to Galderma Group AG’s price movement after its last earnings report?

Galderma Group AG reported an EPS of CHF0.781 in its last earnings report, expectations of CHF0.781. Following the earnings report the stock price went down -9.674%.

Which hedge fund is a major shareholder of Galderma Group AG?

Currently, no hedge funds are holding shares in CH:GALD

GALD Stock 12 Month Forecast

Average Price Target

CHF114.88

▲(19.02%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"67":"CHF67","98":"CHF98","129":"CHF129","82.5":"CHF82.5","113.5":"CHF113.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":128,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF128.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":114.88,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF114.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":105,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF105.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[67,82.5,98,113.5,129],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,110.7,112.03076923076924,113.36153846153846,114.6923076923077,116.02307692307693,117.35384615384615,118.68461538461538,120.01538461538462,121.34615384615384,122.67692307692307,124.00769230769231,125.33846153846153,126.66923076923077,{"y":128,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,110.7,111.02153846153847,111.34307692307692,111.66461538461539,111.98615384615384,112.3076923076923,112.62923076923077,112.95076923076923,113.27230769230769,113.59384615384616,113.91538461538461,114.23692307692308,114.55846153846153,{"y":114.88,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,110.7,110.26153846153846,109.82307692307693,109.38461538461539,108.94615384615385,108.50769230769231,108.06923076923077,107.63076923076923,107.1923076923077,106.75384615384615,106.31538461538462,105.87692307692308,105.43846153846154,{"y":105,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":71.99,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":68.97,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":80.76,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":77.48,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":81.3,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":89.41,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":100.47,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":100.47,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.52,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":109.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.27,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >